Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematopoietic Stem Cell Transplantation, Graft-Versus-Host Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02942173
What this trial is testing

CD45RA Depleted T-cell Infusion for Prevention of Infections After TCRab/CD19-depleted Allo-HSCT

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndromes+3 more
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 150
Testing effectiveness (Phase 2)WithdrawnNCT05604742
What this trial is testing

Belimumab for Treatment of cGVHD Following Allo-HCT

Who this might be right for
cGVHD
xuna
Not applicableUnknownNCT03605953
What this trial is testing

Expansion of Invariant NKT Cells for a Cell Immunotherapeutic Approach Allowing the Control of Graft Versus Host-disease and Preserving the Graft Versus Leukemia Effect After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Allogeneic Hematopoietic Stem Cell (HSC) Transplantation
Central Hospital, Nancy, France 134
Testing effectiveness (Phase 2)Study completedNCT00003838
What this trial is testing

Specialized Blood Cell Transplants for Cancers of the Blood and Bone Marrow

Who this might be right for
Myeloproliferative DisordersAcute Myelogenous LeukemiaChronic Myelogenous Leukemia+2 more
National Heart, Lung, and Blood Institute (NHLBI) 202
Early research (Phase 1)Ended earlyNCT00725062
What this trial is testing

Donor T Cells in Treating Patients With High-Risk Hematologic Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+2 more
Masonic Cancer Center, University of Minnesota 3
Testing effectiveness (Phase 2)Active Not RecruitingNCT05364762
What this trial is testing

Adding Itacitinib to Cyclophosphamide and Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Hematopoietic Stem Cell Transplants

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaChronic Myelomonocytic Leukemia+4 more
City of Hope Medical Center 20
Not applicableActive Not RecruitingNCT00637689
What this trial is testing

Improving Outcomes Assessment in Chronic GVHD

Who this might be right for
Chronic Graft Versus Host Disease
Fred Hutchinson Cancer Center 601
Testing effectiveness (Phase 2)Looking for participantsNCT06681922
What this trial is testing

A Phase I-II Study of High-Dose Post-Transplant Cyclophosphamide, Bortezomib, and Abatacept for the Prevention of Graft-Versus-Host Disease (GVHD) Following Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Who this might be right for
Graft Vs Host Disease
Northwell Health 10
Testing effectiveness (Phase 2)Study completedNCT00504803
What this trial is testing

Mesenchymal Stem Cell Infusion as Prevention for Graft Rejection and Graft-versus-host Disease

Who this might be right for
Hematological Malignancies
University of Liege 30
Testing effectiveness (Phase 2)WithdrawnNCT02694770
What this trial is testing

A Study Evaluating the Efficacy and Safety of Neihulizumab vs "Conventional Treatment" to Treat Sr-aGvHD

Who this might be right for
Steroid-refractory aGvHD Subsequent to Allogeneic Hematopoietic Cell Transplantation
AbGenomics B.V Taiwan Branch
Early research (Phase 1)Ended earlyNCT02436460
What this trial is testing

AbGn-168H in Patients With Steroid Refractory Acute Graft-vs-Host Disease After Donor Stem Cell Transplant

Who this might be right for
Acute Graft Versus Host Disease
AbGenomics B.V Taiwan Branch 4
Testing effectiveness (Phase 2)Study completedNCT03945591
What this trial is testing

High-Dose Post-Transplant Cyclophosphamide and Bortezomib (CyBor) for the Prevention of Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Who this might be right for
GVHD
NYU Langone Health 23
Testing effectiveness (Phase 2)Study completedNCT00813124
What this trial is testing

Azacitidine After Allo Blood And Marrow Transplantation (BMT) for Chronic Myelogenous Leukemia (CML)

Who this might be right for
Stem Cell TransplantationLeukemia
M.D. Anderson Cancer Center 24
Testing effectiveness (Phase 2)Looking for participantsNCT06799195
What this trial is testing

Optimizing GVHD Prophylaxis After Allogeneic Hematopoietic Cell Transplantation

Who this might be right for
Hematological MalignanciesGraft-versus-Host Disease (GVHD)
University of Nebraska 126
Large-scale testing (Phase 3)Study completedNCT03106662
What this trial is testing

Mesenchymal Stem Cell Infusion in Haploidentical Hematopoietic Stem Cell Transplantation in Patients With Hematological Malignancies

Who this might be right for
Hematopoietic Stem Cell Transplantation
Ankara University 6
Early research (Phase 1)Study completedNCT02342613
What this trial is testing

Adoptive Immunotherapy With Activated Marrow Infiltrating Lymphocytes and Cyclophosphamide Graft-Versus-Host Disease Prophylaxis in Patients With Relapse of Hematologic Malignancies After Allogeneic Hematopoietic Cell Transplantation

Who this might be right for
Hematologic MalignanciesGraft-Versus-Host Disease
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 32
Testing effectiveness (Phase 2)UnknownNCT02172924
What this trial is testing

Study Using Placenta Derived Decidual Stromal Cells for Graft Versus Host Disease

Who this might be right for
Graft vs Host Disease
Karolinska Institutet 30
Early research (Phase 1)Ended earlyNCT00473551
What this trial is testing

Anti-Third Party T Lymphocytes With Nonmyeloablative Stem Cell Transplantation for Indolent Lymphoid Malignancies

Who this might be right for
LeukemiaLymphomaMyeloma
M.D. Anderson Cancer Center 4
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07162688
What this trial is testing

Effects of Omega-3 Fatty Acids on Acute Graft-versus-Host Disease After Allogeneic Stem Cell Transplantation.

Who this might be right for
Graft-Versus-Host Disease(GVHD)
Fujian Medical University 30
Large-scale testing (Phase 3)Ended earlyNCT04934670
What this trial is testing

Compare T-Guard vs Ruxolitinib for Treatment of Steroid-Refractory Acute Graft-vs-Host Disease (BMT CTN 2002)

Who this might be right for
Steroid-Refractory Acute Graft Versus Host Disease
Xenikos 12
Next Page